Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Neurons Derived from the Skin Cells of Epilepsy Patients Embody New Platform for Drug Testing

By BiotechDaily International staff writers
Posted on 08 Aug 2013
Print article
Image: This diagram shows the process by which scientists can take skin cells from patients with epilepsy, convert them to stem cells, and then create neurons (brain nerve cells) from them. The induced neurons contain the same genetic mutation(s) carried by the patients (Photo courtesy of the University of Michigan Medical School).
Image: This diagram shows the process by which scientists can take skin cells from patients with epilepsy, convert them to stem cells, and then create neurons (brain nerve cells) from them. The induced neurons contain the same genetic mutation(s) carried by the patients (Photo courtesy of the University of Michigan Medical School).
Stem cells derived from skin taken from juvenile epilepsy patients were induced to mature into cultures of neurons that were developed into a human-based system for the study of the genetic factors that underlie the disorder and for development of drugs to control the disease.

Investigators at the University of Michigan Medical School (Ann Arbor, USA) derived forebrain-like pyramidal- and bipolar-shaped neurons from two Dravet syndrome (DS) subjects and three human controls by iPSC (induced pluripotent stem cell) reprogramming of fibroblasts. DS is a severe form of childhood epilepsy typically caused by dominant mutations in the SCN1A (sodium channel, voltage-gated, type I, alpha subunit) gene encoding the voltage-gated sodium channel Nav1.1.

DS and control iPSC-derived neurons were compared using whole-cell patch clamp recordings. Sodium current density and intrinsic neuronal excitability were also examined. Results published in the July 2, 2013, online edition of the journal the Annals of Neurology revealed that neural progenitors from DS and human control iPSCs displayed a forebrain identity and differentiated into bipolar- and pyramidal-shaped neurons.

DS patient-derived neurons showed increased sodium currents in both bipolar- and pyramidal-shaped neurons. Consistent with increased sodium currents, both types of DS patient-derived neurons showed spontaneous bursting and other evidence of hyperexcitability that could potentially set off seizures. Neurons derived from the skin cells of individuals without epilepsy displayed none of this abnormal activity.

"With this technique, we can study cells that closely resemble the patient's own brain cells, without doing a brain biopsy," said senior author Dr. Jack M. Parent, professor of neurology at the University of Michigan Medical School. "It appears that the cells are overcompensating for the loss of channels due to the mutation. These patient-specific induced neurons hold great promise for modeling seizure disorders, and potentially screening medications."

The findings obtained during this study revealed a previously unrecognized cell-autonomous epilepsy mechanism underlying DS, and offer a platform for screening new antiepileptic therapies.

Related Links:

University of Michigan




Print article

Channels

Drug Discovery

view channel
Image: A scanning electron microscope (SEM) image of methicillin-resistant Staphylococcus aureus bacteria (Photo courtesy of the CDC).

Drug Combination Cures MRSA Infection While Preventing Development of Resistance

Treatment with a combination comprising the well-known antibiotic cefdinir and the experimental drug TXA709 cured mice of drug-resistant staphylococcal infections while reducing the development of resistance.... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel
Image: A three-dimensional printer adapted for stem cell production (Photo courtesy of Nano Dimension).

Israeli Developers Demonstrate Prototype Three-Dimensional Bioprinter

Two Israeli companies have combined efforts in the development of three-dimensional printer technology for the production of stem cells. The three-dimensional print electronics developer Nano Dimension... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.